Earnings Call · Q4 FY2021·2022-02-28

Q4 21EPS +1.79%·Rev n/aQ3 21EPS +12.07%·Rev n/aQ2 21EPS +13.21%·Rev n/aQ1 21EPS +26.79%·Rev n/a⚠ consensus missing

Vaxcyte, Inc. PCVX

Andrew Guggenhime — Investor Relations

Grant Pickering — Chief Executive Officer

Jim Wassil — Chief Operating Officer

Jeff Fairman — VP of Research

+2.9%1d on move date+4.4% vs SPY3d+1.3%5d−0.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PCVX calls or request research access.

More PCVX calls Browse calls Request research access